TickerFacts.

Cytek Biosciences, Inc. (CTKB): Operating Income

Annual figures by period end, from SEC filings.

-$40.38M
Year ended 2025-12-31
-$44.65M
Trailing 12 months to 2026-06-30
$13.66M2020-12-31: $13.66M2021-12-31: $9.16M2022-12-31: -$1.80M2023-12-31: -$27.84M2024-12-31: -$20.52M2025-12-31: -$40.38M-$40.38M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$40.38Mn/m2026-02-26, From 2025-01-01
2024-12-31-$20.52Mn/m2026-02-26, From 2024-01-01
2023-12-31-$27.84Mn/m2026-02-26, From 2023-01-01
2022-12-31-$1.80Mn/m2025-02-28, From 2022-01-01
2021-12-31$9.16M-33.0%2024-03-13, From 2021-01-01
2020-12-31$13.66Mn/a2023-03-01, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Cytek Biosciences, Inc. (CTKB)2025-12-31-$40.38Mn/m
Pacific Biosciences of California, Inc. (PACB)2025-12-31-$553.86Mn/m
Quanterix Corp (QTRX)2025-12-31-$125.54Mn/m
Harvard Bioscience Inc (HBIO)2025-12-31-$48.58Mn/m
10x Genomics, Inc. (TXG)2025-12-31-$60.98Mn/m
908 Devices Inc. (MASS)2025-12-31-$39.42Mn/m
Rapid Micro Biosystems, Inc. (RPID)2025-12-31-$47.39Mn/m
EyePoint, Inc. (EYPT)2025-12-31-$243.43Mn/m
Bionano Genomics, Inc. (BNGO)2025-12-31-$33.34Mn/m

Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗